The estimated Net Worth of Barbara J Mcneil is at least $3.98 Milione dollars as of 4 February 2016. Barbara Mcneil owns over 4,000 units of Edwards Lifesciences Corp stock worth over $3,170,486 and over the last 19 years Barbara sold EW stock worth over $813,720.
Barbara has made over 5 trades of the Edwards Lifesciences Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Barbara sold 4,000 units of EW stock worth $333,160 on 4 February 2016.
The largest trade Barbara's ever made was selling 4,000 units of Edwards Lifesciences Corp stock on 4 February 2016 worth over $333,160. On average, Barbara trades about 522 units every 96 days since 2006. As of 4 February 2016 Barbara still owns at least 46,454 units of Edwards Lifesciences Corp stock.
You can see the complete history of Barbara Mcneil stock trades at the bottom of the page.
Barbara's mailing address filed with the SEC is C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE, CA, 92614.
Over the last 22 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo e Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: